References
- Faulds MH, Dahlman-Wright K. Metabolic diseases and cancer risk. Curr Opin Oncol 2012;24:58–61
- Lacey JV, Chia VM. Endometrial hyperplasia and the risk of progression to carcinoma. Maturitas 2009;63:39–44
- Hecht JL, Mutter GL. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol 2006;24:4783–91
- Zhang Y, Liu Z, Yu X, et al. The association between metabolic abnormality and endometrial cancer: a large case-control study in China. Gynecol Oncol 2010;17:41–6
- Rosato V, Zucchetto A, Bosetti C, et al. Metabolic syndrome and endometrial cancer risk. Ann Oncol 2011;22:884–9
- Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet 2005;366:491–505
- Cust AE, Kaaks R, Friedenreich C, et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2007;14:755–67
- Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). J Am Med Assoc 2001;285:2486–97
- US Department of Health and Human Services, Public Health Service, National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, MD: NIH Publication; 1998:98–4080
- Furberg AS, Jasienska G, Bjurstam N, et al. Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer Epidemiol Biomarkers Prev 2005;14:33–40
- Furberg AS, Thune I. Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer 2003;104:669–76
- Bandera EV, Kushi LH, Moore DF, et al. Dietary lipids and endometrial cancer: the current epidemiologic evidence. Cancer Causes Control 2007;18:687–703
- Lindemann K, Vatten LJ, Ellstrøm-Engh M, Eskild A. Serum lipids and endometrial cancer risk: results from the HUNT-II study. Int J Cancer 2009;124:2938–41
- Swanson CA, Potischman N, Barrett RJ, et al. Endometrial cancer risk in relation to serum lipids and lipoprotein levels. Cancer Epidemiol Biomarkers Prev 1994;3:575–81
- Goldman NA, Katz EB, Glenn AS, et al. GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma. Mod Pathol 2006;19:1429–36
- Levran D, Modan M, Menczer J, Dulitzy M. Increased rate of glucose intolerance in endometrial cancer – a community-based study. Gynecol Obstet Invest 1984;18:190–3
- Rutanen EM, Stenman S, Blum W, et al. Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls. J Clin Endocrinol Metab 1993;77:199–204
- Weiderpass E, Persson I, Adami HO, et al. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000;11:185–92
- Anderson KE, Anderson E, Mink PJ, et al. Diabetes and endometrial cancer in the Iowa women’s health study. Cancer Epidemiol Biomarkers Prev 2001;10:611–16
- Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625–38
- Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–78
- Parazzini F, La Vecchia C, Bocciolone L, Franceschi S. The epidemiology of endometrial cancer. Gynecol Oncol 1991;41:1–16
- Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/-National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735–52
- Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415–28
- Hirasawa A, Makita K, Akahane T, et al. Hypertriglyceridemia is frequent in endometrial cancer survivors. Jpn J Clin Oncol 2013;43:1087–92